Blog

CRISPR and Gene Editing Applications in PDX for Functional Genomics and Drug Target Validation

Introduction Patient-Derived Xenografts (PDX) have emerged as powerful translational platforms due to their ability to conserve genetic heterogeneity and phenotypic complexity of patient tumors. The advent of CRISPR/Cas9 and other

Modeling Immune Checkpoint Inhibitor Response in Humanized Xenograft Systems

Introduction Immune checkpoint inhibitors (ICIs) targeting pathways such as PD-1/PD-L1 and CTLA-4 have revolutionized cancer therapy, but their efficacy varies widely among patients. Traditional xenograft models, established in immunodeficient mice,

The Role of the Tumor Microenvironment in Xenograft Tumorigenesis and Therapeutic Response

Introduction The tumor microenvironment (TME) is a dynamic ecosystem composed of stromal cells, immune infiltrates, vasculature, extracellular matrix (ECM), and soluble signaling factors. It plays a critical role in tumor

Multi-Omics Integration in Xenograft Research: Genomic, Transcriptomic, and Proteomic Profiling

Introduction Xenograft models, particularly patient-derived xenografts (PDX), provide unparalleled opportunities to study tumor biology in a living system. However, to fully exploit their potential, researchers increasingly integrate multi-omics profiling—genomics, transcriptomics,

Advanced Murine Xenograft Methodologies: Orthotopic, Metastatic, and Disseminated Models

Introduction Conventional subcutaneous xenograft models provide accessible and reproducible systems for studying tumor growth, but they lack the anatomical and physiological context of the original tumor site. To address this,

Next-Generation Alternatives: Organoids, Organoid-on-a-Chip, and Ex Vivo Tumor Explants

Introduction While xenograft models remain the gold standard for studying human tumor biology in vivo, the demand for more rapid, cost-effective, and human-relevant systems has accelerated the development of next-generation

Comparative Xenograft Models Across Tumor Types: Breast, Colorectal, Pancreatic, Glioblastoma

Introduction Xenograft models are versatile platforms for investigating diverse cancer types, each presenting unique challenges in tumor biology, therapeutic targeting, and translational predictivity. Comparative analyses across tumor types highlight how

Mechanisms of Therapy Resistance in Xenografts: Epigenetic and Microenvironmental Drivers

Introduction One of the most pressing challenges in oncology is the emergence of therapy resistance. Even when initial responses are robust, tumors frequently recur in more aggressive, treatment-refractory forms. Xenograft

Applications of PDX in Co-Clinical Trials and Personalized Medicine Workflows

Introduction Patient-Derived Xenografts (PDX) have redefined translational oncology by directly linking preclinical research to clinical decision-making. Beyond their role in drug discovery, PDX models are increasingly employed in co-clinical trials,

Quality Control, Genetic Drift, and Reproducibility Challenges in Long-Term Xenograft Studies

Introduction Xenograft models have transformed preclinical oncology by providing in vivo systems that retain many biological and molecular features of human tumors. Yet, long-term use of these models introduces significant